LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) ANNOUNCEMENT PROGRESS OF ACQUISITION AND CONSTRUCTION OF PROPERTIES I. Progress of the Transaction On February 28, 2018, the Company’s Guangdong bra]

By | 2018-03-12T13:02:18+00:00 March 12th, 2018|Categories: Chinese Stocks, LFC, SEC Original|Tags: , , , , , |0 Comments

IDI [Cogint] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): March 8, 2018 Cogint, Inc. Delaware 001-37893 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 ________________]

By | 2018-03-13T02:02:30+00:00 March 12th, 2018|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint

[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) ANNOUNCEMENT PROGRESS OF ACQUISITION AND CONSTRUCTION OF PROPERTIES I. Progress of the Transaction On February 28, 2018, the Company’s Guangdong bra]

By | 2018-03-12T13:02:24+00:00 March 12th, 2018|Categories: Chinese Stocks, LFC, Webplus ver|Tags: , , , , , |0 Comments

IDI [Cogint] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): March 8, 2018 Cogint, Inc. Delaware 001-37893 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 ________________]

By | 2018-03-13T02:02:34+00:00 March 12th, 2018|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Receipt of Proposal from Yunfeng Capital and Alibaba BEIJING, March 12, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), The Special Committee has received a proposal from Yunfeng and Alibaba Investment Limited (“Alibaba”), proposing a t]

FENG [Phoenix New Media] 6-K: (Original Filing)

[Phoenix New Media Reports Fourth Quarter and Fiscal Year 201 7 Unaudited Financial Results Live Conference Call to be Held at 9 :00 P M U.S. Eastern Time on March 12, 2018 BEIJING, China, “We are very pleased to A Journey through Literature, The unique value proposition offered by our programmatic a]

By | 2018-03-13T02:03:43+00:00 March 12th, 2018|Categories: Chinese Stocks, FENG, SEC Original|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] 6-K: iKang Announces Receipt of Proposal from Yunfeng Capital

[iKang Announces Receipt of Proposal from Yunfeng Capital and Alibaba BEIJING, March 12, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), The Special Committee has received a proposal from Yunfeng and Alibaba Investment Limited (“Alibaba”), proposing a t]

FENG [Phoenix New Media] 6-K: Phoenix New Media Reports Fourth Quarter and Fiscal

[Phoenix New Media Reports Fourth Quarter and Fiscal Year 201 7 Unaudited Financial Results Live Conference Call to be Held at 9 :00 P M U.S. Eastern Time on March 12, 2018 BEIJING, China, “We are very pleased to A Journey through Literature, The unique value proposition offered by our programmatic a]

By | 2018-03-13T02:03:48+00:00 March 12th, 2018|Categories: Chinese Stocks, FENG, Webplus ver|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: (Original Filing)

[AMERICA-ASIA DIABETES RESEARCH FOUNDATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS ASSETS December 31 December 31 December 31, 2017 2016 2015 CURRENT ASSETS Cash and cash equivalents $ 138,431 $ 325,406 $ 2,792,374 Short-term investment - time deposits - - 81,444 Accounts receivable, n]

OSN [Ossen Innovation] 6-K: AMERICA-ASIA DIABETES RESEARCH FOUNDATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED

[AMERICA-ASIA DIABETES RESEARCH FOUNDATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS ASSETS December 31 December 31 December 31, 2017 2016 2015 CURRENT ASSETS Cash and cash equivalents $ 138,431 $ 325,406 $ 2,792,374 Short-term investment - time deposits - - 81,444 Accounts receivable, n]

Skip to toolbar